I had the opportunity to sit down with Dr. George Yancopoulos, Co-founder, President, and Chief Scientific Officer for Regeneron Pharmaceuticals, to talk about why they decided to invest in ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

George Yancopoulos is co-founder and chief scientific officer of Regeneron, a US biotech that is one of over 80 companies ...

Moments after Regeneron CEO Len Schleifer scolded analysts for asking too many questions about the disappointing sales of eye ...

Hegseth was confirmed after a 50-50 vote in the Senate, when Vice President JD Vance came to the chamber to break the tie in his role as president of the Senate.

Regeneron co-Chair, President and CSO George Yancopoulos discusses the company's planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco. South Korean ...

it has been increasingly recognized that the profound weight loss is accompanied by substantial muscle loss," Regeneron Pharmaceuticals Chief Scientific Officer George Yancopoulos said on the ...

George Yancopoulos. Additionally, Regeneron (REGN) and Sanofi (SNY) updated investors on their Phase 3 program for Dupixent ...

Leonard Schleifer; Co-Chairman of the Board, President, Chief Executive Officer, Founder; Regeneron Pharmaceuticals Inc George Yancopoulos; Co-Chairman of the Board, President, Chief Scientific ...